Collectively, these data demonstrate that CMS5 rechallenge stimulates the expansion of sTRM and promotes the recruitment of T cells into the skin with increased long-term survival by elevating expressions of IL-7 and IL-15 in the skin and enhancing the secretion of inflammatory cytokines IFNγ and TNFα to repel tumor. The gene discussed is IL7; the disease is neoplasm.